5-HT₃ receptor antagonists

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.8, Iss.12, 1999-12, pp. : 2183-2188

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advances in use of the 5-HT3 receptor antagonists

By Walton S.M.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 2, 2000-01 ,pp. : 207-223

Informa Healthcare

Access to resources Recommend Favorite

Are All 5-HT3 Receptor Antagonists the Same?

By McNulty Robert

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 5, Iss. 1, 2007-01 ,pp. : 35-43

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Clinical Pharmacology of Serotonin Receptor Type 3 (5-HT3) Antagonists

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 1, Iss. 2, 2001-08 ,pp. : 171-199

Bentham Science Publishers

Access to resources Recommend Favorite

The Effect of 5-HT 3 Receptor Antagonists on the Writhing Response in Mice

By Moser P.C.

General Pharmacology, Vol. 26, Iss. 6, 1995-10 ,pp. : 1301-1306

Elsevier

Access to resources Recommend Favorite

Reversal of neuroleptic-induced orofacial dyskinesia by 5-HT 3 receptor antagonists

By Naidu P.S. Kulkarni S.K.

European Journal of Pharmacology, Vol. 420, Iss. 2, 2001-05 ,pp. : 113-117

Elsevier

Access to resources Recommend Favorite